An exportonly exception to pharmaceutical patents in Europe should the United States follow suit httpsgo.nature.com2VHHRJzÂpic.twitter.comVhayfwfD3s

An export-only exception to pharmaceutical patents in Europe: should the United States follow suit? https://go.nature.com/2VHHRJz pic.twitter.com/VhayfwfD3s

14:01 EST 11 Jan 2019 | Nature Publishing

An export-only exception to pharmaceutical patents in Europe: should the United States follow suit? https://go.nature.com/2VHHRJz  pic.twitter.com/VhayfwfD3s

More From BioPortfolio on "An export-only exception to pharmaceutical patents in Europe: should the United States follow suit? https://go.nature.com/2VHHRJz pic.twitter.com/VhayfwfD3s"